RISPERDAL® CONSTA® (risperidone) Long Acting Injection

Understanding Schizophrenia
Treatment of Schizophrenia
Importance of Staying on Treatment
RISPERDAL CONSTA: A Different Option
The Mental Healthcare Team
Recognizing the Signs of Relapse
Psychosocial Treatment, Rehabilitation and Support
Taking Care of Yourself
News Center
Resources
For Patients
For Healthcare Providers
También en Español
Full US Prescribing Information
Sitemap
Global Resources
Tell a friend
Privacy Policy
Legal Notice
Printer Friendly
 Text Size:  S | M |  L
 
 
 
    

Understanding Schizophrenia

Schizophrenia is a serious mental disorder that affects a person's ability to think and function well. Perceptions, feelings, and behavior become impaired, making it difficult for the person to manage emotions, make decisions, and relate to other people.

One way to think of the illness is as an out-of-control switching system in the brain. The processes that produce appropriate thoughts and actions in most people become jumbled in the brain of a person with schizophrenia. Because the brain is often overloaded, people with schizophrenia can experience the following symptoms:

  • Hallucinations: seeing, hearing, tasting, touching, or smelling things that others do not
  • Delusions: belief in ideas that are obviously false
  • Oversensitivity or undersensitivity to the stimuli around them, because the brain has trouble sorting out information
  • Inappropriate emotions, such as laughing at sad news

More than 2 million Americans (about 1 percent of the population) suffer from schizophrenia – which is no small number when you consider that it also affects millions of families who know what it means to care for a family member with the illness. Symptoms usually start in the late teens or early to mid-twenties. Schizophrenia does not discriminate – it affects men and women with equal frequency, regardless of geographic location and economic status.

<Back to Top>


Staying Connected

Despite its prevalence, many families are reluctant to talk about the illness for fear of being stigmatized. Some become socially isolated, keeping to themselves and trying to handle everything on their own. To assist in the overall treatment, it is important that both you and your friend or relative remain connected with friends and family and the healthcare team.

To best help your friend or relative you need to have access to the latest treatment information. By connecting with other families living with mental illnesses you will not feel so isolated and you can also share the challenge of caring for someone with schizophrenia. There are counseling services and other support services available to help guide you through the treatment process and there are various organizations that offer information and support to patients and families living with schizophrenia and other mental illnesses.

Please visit our resource center to access some of these services.


To learn more about schizophrenia, visit the following Web sites:

The National Alliance for the Mentally Ill (NAMI)

The National Alliance for the Mentally Ill, NAMI is a nonprofit, grassroots, self-help, support and advocacy organization of consumers, families, and friends of people with severe mental illnesses, such as schizophrenia, bipolar disorder, major depressive disorder, obsessive-compulsive disorder, panic and anxiety disorders.

With more than one thousand local affiliates and fifty state organizations NAMI provides education and support, combat stigma, support increased funding for research, and advocate for adequate health insurance, housing, rehabilitation, and jobs for people with mental illnesses and their families.

National Institute of Mental Health (NIMH)

The NIMH is a Federal agency whose mission is to reduce the burden of mental illness through research. The agency utilizes powerful scientific tools to achieve better understanding, treatment, and eventually, prevention of mental illnesses that affect millions of Americans. This Web site provides comprehensive information on mental illnesses and the available treatment options.

The National Mental Health Association (NMHA)

The National Mental Health Association (NMHA) is the country's oldest and largest nonprofit organization addressing all aspects of mental health and mental illness. With more than 340 affiliates nationwide, NMHA works to improve the mental health of all Americans, especially the 54 million individuals with mental disorders, through advocacy, education, research and service.

Schizophrenia.com

Schizophrenia.com is a not-for-profit resource center that provides information, support and education to patients, caregivers and family members, whose lives have been impacted by schizophrenia. The site is run by volunteers whose lives have been impacted by the disease (patients and caregivers).

<Back to Top>



    

Staying connected


Message of Hope
Message of Hope
Send a free message of hope. Click here.
Frequently Asked Questions
Frequently Asked Questions
For frequently asked questions about RISPERDAL CONSTA, click here.

 


RISPERDAL® CONSTA® (risperidone) is used for the treatment of schizophrenia.

IMPORTANT SAFETY INFORMATION FOR RISPERDAL® CONSTA®

Elderly Patients with dementia-related psychosis treated with atypical antipsychotic drugs are at an increased risk of death compared to placebo. RISPERDAL® CONSTA® (risperidone) is not approved for the treatment of patients with dementia-related psychosis.

Neuroleptic Malignant Syndrome (NMS) is a rare and potentially fatal side effect reported with RISPERDAL® CONSTA® and similar medicines. Call your doctor immediately if the person being treated develops symptoms such as high fever; stiff muscles; shaking; confusion; sweating; changes in pulse, heart rate, or blood pressure; or muscle pain and weakness. Treatment should be stopped if the person being treated has NMS.

Tardive Dyskinesia (TD) is a serious, sometimes permanent side effect reported with RISPERDAL® CONSTA® and similar medications. TD includes uncontrollable movements of the face, tongue, and other parts of the body. The risk of developing TD and the chance that it will become permanent is thought to increase with the length of therapy and the overall dose taken by the patient. This condition can develop after a brief period of therapy at low doses, although this is much less common. There is no known treatment for TD, but it may go away partially or completely if therapy is stopped.

High blood sugar and diabetes have been reported with RISPERDAL® CONSTA® and similar medications. If the person being treated has diabetes or risk factors such as being overweight or a family history of diabetes, blood sugar testing should be performed at the beginning and throughout treatment with RISPERDAL® CONSTA®. Complications of diabetes can be serious and even life threatening. If signs of high blood sugar or diabetes develop, such as being thirsty all the time, going to the bathroom a lot, or feeling weak or hungry, contact your doctor.

RISPERDAL® CONSTA® and similar medications can raise the blood levels of a hormone known as prolactin, causing a condition known as hyperprolactinemia. Blood levels of prolactin remain elevated with continued use. Some side effects seen with these medications include the absence of a menstrual period; breasts producing milk; the development of breasts by males; and the inability to achieve an erection. The connection between prolactin levels and side effects is unknown.

Some people taking RISPERDAL® CONSTA® may feel faint or lightheaded when they stand up or sit up too quickly. By standing up or sitting up slowly and following your healthcare professional's dosing instructions, this side effect can be reduced or it may go away over time.

RISPERDAL® CONSTA® may affect your alertness or driving ability; therefore, do not drive or operate machinery before talking to your healthcare professional.

RISPERDAL® CONSTA® should be used cautiously in people with a seizure disorder, who have had seizures in the past, or who have conditions that increase their risk for seizures.

Extrapyramidal Symptoms (EPS) are usually persistent movement disorders or muscle disturbances, such as restlessness, tremors, and muscle stiffness. If you observe any of these symptoms, talk to your healthcare professional.

Inform your healthcare professional if you become pregnant or intend to become pregnant during therapy with RISPERDAL® CONSTA®. Caution should be exercised when RISPERDAL® CONSTA® is administered to a nursing woman.

RISPERDAL® CONSTA® may make you more sensitive to heat. You may have trouble cooling off, or be more likely to become dehydrated, so take care when exercising or when doing things that make you warm.

Some medications interact with RISPERDAL® CONSTA®. Please inform your healthcare professional of any medications or supplements that you are taking. Avoid alcohol while on RISPERDAL® CONSTA®.

In a study of people taking RISPERDAL® CONSTA®, the most common side effects in the treatment of schizophrenia were headache, tremors, dizziness, restlessness, tiredness, constipation, indigestion, sleepiness, weight gain, pain in the limbs, and dry mouth.

If you have any questions about RISPERDAL® CONSTA® or your therapy, talk with your doctor.

For more information, read the Important Product Information by clicking here.

01CS1054




Janssen, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc.

Home   Janssen.com   Site Map   Contact Us   

© Ortho-McNeil-Janssen Pharmaceuticals, Inc. 2003 – 2008. This site is published by Janssen®, Division of Ortho-McNeil-Janssen Pharmaceuticals, Inc. which is solely responsible for its contents. This site is intended for visitors from the United States.
This page was last updated on: Jan 18 2008 at 13:40:59 EST